Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Operating expenses        
Research and development $ 880,672 $ 428,529 $ 1,490,328 $ 1,228,141
General and administrative 949,002 792,129 2,076,608 2,203,725
Total operating expenses 1,829,674 1,220,658 3,566,936 3,431,866
Operating loss (1,829,674) (1,220,658) (3,566,936) (3,431,866)
Other expense (income)        
Change in fair value of derivative liabilities 120,648 26,353 358,998 (9,550)
Interest expense 190,058 171,625 374,963 337,980
Gain on forgiveness of PPP loan (117,953) 0 (117,953) 0
Total other expense, net 192,753 197,978 616,008 328,430
Loss before income taxes (2,022,427) (1,418,636) (4,182,944) (3,760,296)
Provision for income taxes 1,600 1,600 1,600 1,600
Net loss (2,024,027) (1,420,236) (4,184,544) (3,761,896)
Comprehensive loss $ (2,024,027) $ (1,420,236) $ (4,184,544) $ (3,761,896)
Loss per common share:        
Basic (in dollars per share) $ (0.01) $ (0.01) $ (0.01) $ (0.02)
Diluted (in dollars per share) $ (0.01) $ (0.01) $ (0.01) $ (0.02)
Weighted average shares of common stock outstanding used to compute earnings per share:        
Basic (in shares) 378,427,575 183,052,175 357,770,295 182,654,571
Diluted (in shares) 378,427,575 183,052,175 357,770,295 182,654,571